We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Highly Aligned Nanofibers Developed for Tissue Engineering Applications

By LabMedica International staff writers
Posted on 10 Mar 2014
A team of biomedical engineers has constructed a uniform highly aligned nanoscale fibrous scaffolding from extracellular matrix (ECM) naturally deposited by fibroblasts to be used for potential tissue engineering applications.

When placed in contact with ECM obtained from epithelial cells or fibroblasts, cells attach quickly, exhibit high plating and cloning efficiencies, proliferate rapidly, reach a high saturation density, exhibit lower requirements for serum and added growth factors, respond better to physiologically occurring hormones, express differentiated functions, have longer life span, undergo flattening and morphological changes, and have better plating consistency. More...
Such cells adopt growth characteristics, morphological appearance, and biological responses that are not expressed when the same cells are maintained on artificial substrata (plastic, glass), even if coated with isolated constituents of ECM such as purified collagen or glycoproteins.

Investigators at Michigan Technological University (Houghton, USA) used synthetic nanogratings (130 nanometers in depth) to direct the growth of human dermal fibroblasts for up to eight weeks, resulting in a uniform 70 micrometer-thick fibroblast cell sheet with highly aligned cells and ECM nanofibers. A natural ECM scaffolding with uniformly aligned nanofibers about 78 nanometers in diameter was generated after removing the cellular components from the fibroblast sheet.

In a report published in the January 29, 2014, online edition of the journal Advanced Functional Materials the investigators demonstrated the excellent capacity of the ECM-scaffolding in directing and supporting alignment and proliferation of reseeded human mesenchymal stem cells (hMSCs) along the underlying fibers. Furthermore, the aligned ECM scaffolding induced a significantly lower immune response compared to its unaligned counterpart, as detected by proinflammatory cytokines secreted from macrophages.

“The cells did the work,” said senior author Dr. Feng Zhao, assistant professor of biomedical engineering at Michigan Technological University. “The material they made is quite uniform, and of course it is completely biological. We think this has great potential. I think we could use this to engineer softer tissues, like skin, blood vessels, and muscle.”

Related Links:

Michigan Technological University



New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Serological Pipet Controller
PIPETBOY GENIUS
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.